C50.629
Malignant neoplasm of axillary tail of unspecified male breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the axillary tail of the male breast refers to a type of breast cancer that originates in the axillary tail, a small extension of breast tissue located in the armpit area. This condition is classified under the ICD-10 code C50.629 and is specifically diagnosed in males. Although breast cancer is more common in women, men can also develop this disease, often at a later stage due to lack of routine screening. Recognizing this condition early is crucial for effective treatment and improved outcomes.
Causes & Symptoms
Clinical Causes: Genetic mutations, such as in the BRCA1 and BRCA2 genes Family history of breast cancer Hormonal imbalances that increase estrogen levels Radiation exposure to the chest area Previous personal history of breast cancer or other cancers Age-related changes, with higher incidence in older men Lifestyle factors, including obesity and alcohol consumption Certain inherited syndromes that increase cancer risk
Key Symptoms: Presence of a painless lump or mass in the armpit or breast area Swelling or thickening of the breast tissue Skin changes over the breast or axillary area, such as redness or puckering Nipple retraction or discharge from the nipple Persistent pain or discomfort in the breast or armpit Lumps that may be fixed or movable upon palpation Unexplained weight loss or general fatigue in advanced cases
Diagnostic & Treatment
Diagnosis Path: The diagnosis of malignant neoplasm in the axillary tail involves several steps, including: - Physical examination to detect lumps or abnormalities - Imaging techniques such as mammography, ultrasound, or MRI to visualize the tissue - Biopsy procedures, like core needle biopsy or excisional biopsy, to confirm cancerous cells - Additional tests like ultrasound of lymph nodes or CT scans to determine the spread of cancer - Hormone receptor testing and other molecular analyses to guide treatment options Early detection often relies on awareness of symptoms and regular clinical evaluations, especially for those with risk factors.
Treatment Protocols: Treatment strategies for malignant neoplasm of the axillary tail generally involve a multidisciplinary approach, which may include: - Surgical removal of the tumor, ranging from lumpectomy to mastectomy depending on the extent - Axillary lymph node dissection or sentinel lymph node biopsy to assess spread - Radiation therapy to target remaining cancer cells in the breast or armpit area - Systemic therapies such as chemotherapy, hormone therapy, or targeted therapy based on tumor characteristics - Supportive care to manage side effects and improve quality of life Prognosis depends on the stage at diagnosis, tumor size, lymph node involvement, and molecular features of the cancer.
Clinical Advice & FAQs
Billing Guidance
Is C50.629 a billable ICD-10 code?
Yes, C50.629 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C50.629?
Clinical documentation must specify the nature of Malignant neoplasm of axillary tail of unspecified male breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference